These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7498364)

  • 1. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
    Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective and restorative role of AS101 in combination with chemotherapy.
    Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Horwith G; Kirsch T; Maida B; Sehgal SN; Sredni B
    Cancer Res; 1991 Mar; 51(5):1499-503. PubMed ID: 1997189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
    Kalechman Y; Zuloff A; Albeck M; Strassmann G; Sredni B
    Blood; 1995 Mar; 85(6):1555-61. PubMed ID: 7888674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
    Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
    Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action.
    Kalechman Y; Shani A; Sotnik-Barkai I; Albeck M; Sredni B
    Cancer Res; 1993 Dec; 53(24):5962-9. PubMed ID: 8261410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of murine cytomegalovirus (MCMV) induced myelosuppression by AS101.
    Sredni B; Rosenthal-Galili Z; Michlin H; Sobelman D; Seger Y; Blagerman S; Kalechman Y; Rager-Zisman B
    Immunol Lett; 1994 Dec; 43(3):159-65. PubMed ID: 7721328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin.
    Kalechman Y; Albeck M; Sredni B
    Cell Immunol; 1992 Aug; 143(1):143-53. PubMed ID: 1623562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.
    Sredni B; Albeck M; Tichler T; Shani A; Shapira J; Bruderman I; Catane R; Kaufman B; Kalechman Y
    J Clin Oncol; 1995 Sep; 13(9):2342-53. PubMed ID: 7666093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioprotective effects of the immunomodulator AS101.
    Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Seghal SN; Sredni B
    J Immunol; 1990 Sep; 145(5):1512-7. PubMed ID: 2384668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic effects and mechanisms of Fufang e׳jiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice.
    Liu M; Tan H; Zhang X; Liu Z; Cheng Y; Wang D; Wang F
    J Ethnopharmacol; 2014 Mar; 152(3):575-84. PubMed ID: 24534527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
    Kalechman Y; Gafter U; Gal R; Rushkin G; Yan D; Albeck M; Sredni B
    J Immunol; 2002 Jul; 169(1):384-92. PubMed ID: 12077268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor.
    Bartucci M; Dattilo R; Martinetti D; Todaro M; Zapparelli G; Di Virgilio A; Biffoni M; De Maria R; Zeuner A
    Clin Cancer Res; 2011 Oct; 17(19):6185-91. PubMed ID: 21868766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
    Kalechman Y; Shani A; Albeck M; Sredni B
    Immunopharmacology; 1995 Mar; 29(2):149-58. PubMed ID: 7539780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.
    Shibuya K; Akahori H; Takahashi K; Tahara E; Kato T; Miyazaki H
    Blood; 1998 Jan; 91(1):37-45. PubMed ID: 9414267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
    Wu DD; Nayar R; Keating A
    Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.